East Coast Customer Base Continues Growth for Global Med Technologies(R), Inc.
August 25 2005 - 11:00AM
PR Newswire (US)
Community Blood Council of New Jersey Licenses SafeTrace(R) Donor
Management System DENVER, Aug. 25 /PRNewswire-FirstCall/ --
Wyndgate Technologies(R), a division of Global Med Technologies(R),
Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) ("Global Med" or the
"Company"), has signed an agreement with Community Blood Council of
New Jersey ("CBC-NJ") to provide CBC-NJ with its SafeTrace(R) donor
management system. Terms were not disclosed. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) Jim
Gosnay, CEO of Community Blood Council of New Jersey, stated, "Our
staff selected Wyndgate's SafeTrace donor management system for its
comprehensive safety features, as well as its application
capabilities, which will facilitate the automation of many of the
manual processes currently being performed in our donor service.
Wyndgate, with its expertise in the blood bank industry, has
successfully developed software to manage the complexities of our
donor facility. Community Blood Council of New Jersey decided to
purchase Wyndgate's system because of its blood bank market
experience, application functionality, product lifecycle,
implementation experience and product support. Most importantly,
Wyndgate was able to deploy our needs for an Application Service
Provider (ASP) through Hemo-Net, a provider of blood donor software
solutions, which required no outlay by CBC-NJ for ancillary
hardware, third-party software or other required yearly services."
Wm. Scott Dustin, Vice President of Sales & Marketing for
Wyndgate Technologies, said, "We are very pleased to announce this
major agreement with Community Blood Council of New Jersey, a
prestigious community blood center in central New Jersey. Through
our relationship with Hemo-Net, Wyndgate is able to provide our
customers with another option for deploying our SafeTrace donor
software solution. This relationship highlights Wyndgate's
commitment to quality, safety and service, by partnering with
CBC-NJ and Hemo-Net to optimize donor operations." About Community
Blood Council of New Jersey Community Blood Council of New Jersey
is located in the Trenton, Mercer County area serving New Jersey,
and also the Bucks County area serving Pennsylvania. CBC-NJ has
provided blood support in the region for over 30 years. For more
information about Community Blood Council of New Jersey, visit
http://www.communitybloodcouncil.org/. About Hemo-Net, LLC Hemo-Net
offers more than 30 years of technical computer experience,
specializing in blood donor management and transfusion medicine
software applications. As an application service provider, Hemo-Net
partners with Wyndgate Technologies to provide quality service in
helping blood centers advance their donor tracking, safety and
disaster protection. Hemo-Net is a Bonfils Blood Center subsidiary.
About Global Med Technologies, Inc. Global Med Technologies, Inc.
is an international e-Health, medical information technology
company, providing information management software products and
services to the healthcare industry. Its Wyndgate Technologies
division is a leading supplier of information management systems to
U.S. and international blood centers and hospital transfusion
centers. Current clients of Wyndgate's products and services manage
more than 3 million units of blood, or over 22% of the U.S. blood
supply, each year. Wyndgate's products are also being implemented
in Canada, the Caribbean and sub-Sahara Africa. Together, the
SafeTrace Tx(R)* advanced transfusion management system and the
SafeTrace donor management system provide Vein-to-Vein(R) tracking
from donor collection to patient transfusion. For more information
about Global Med's products and services, please call 800-WYNDGATE
or visit http://www.globalmedtech.com/, http://www.peoplemed.com/
and http://www.wyndgate.com/. This news release may include
statements that constitute forward-looking statements, usually
containing the words "believe," "estimate," "project," "expects" or
similar expressions. These statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release. * Patent pending
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies,
Inc., +1-303-238-2000; or Investor Relations, John Nesbett or
Jordan Silverstein, both of The Investor Relations Group,
+1-212-825-3210, for Global Med Technologies, Inc. Web site:
http://www.communitybloodcouncil.org/ Web site:
http://www.peoplemed.com/ Web site: http://www.wyndgate.com/ Web
site: http://www.globalmedtech.com/
Copyright